Neurocrine Biosciences (NBIX) Goodwill & Intangibles (2009 - 2026)
Neurocrine Biosciences' Goodwill & Intangibles came in at $2.69 billion for Q3 2026, compared with $35.7 million a year earlier and down 1.3% from the prior quarter.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Goodwill & Intangibles (2009 - 2026) Analysis & Trends
At the end of FY2025, Neurocrine Biosciences' Goodwill & Intangibles was $10.8 million, down 74.4% from FY2024.
- Goodwill & Intangibles carries a three-year compound annual growth rate of -36.7% (FY2022 to FY2025).
- Going back by year, Goodwill & Intangibles was $42.2 million in FY2024 (+2.2%), $41.3 million in FY2023 (-3.1%) and $42.6 million in FY2022.
- The five-year range for quarterly Goodwill & Intangibles is $6 million (Q1 2026) to $2.73 billion (Q2 2026).
- Year-over-year, Goodwill & Intangibles increased in 1 of the last six quarters, with an average decline of 30.3%.
- The fastest year-over-year change in Goodwill & Intangibles over five years came in Q4 2024 (growth of 2.2%), and the weakest in Q1 2026 (a decline of 83.5%).
- Business Quant data shows NBIX's Goodwill & Intangibles at $2.73 billion (Q2 2026), $6 million (Q1 2026) and $10.8 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Neurocrine Biosciences | 17.13 Bn | 13.21 Bn | 1.10 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 2.69 Bn |
| Jun 30, 2026 | 2.73 Bn |
| Mar 31, 2026 | 6.00 Mn |
| Dec 31, 2025 | 10.80 Mn |
| Sep 30, 2025 | 35.70 Mn |
| Jun 30, 2025 | 37.20 Mn |
| Mar 31, 2025 | 36.40 Mn |
| Dec 31, 2024 | 42.20 Mn |
| Sep 30, 2024 | 40.60 Mn |
| Jun 30, 2024 | 39.20 Mn |
| Mar 31, 2024 | 40.00 Mn |
| Dec 31, 2023 | 41.30 Mn |
| Sep 30, 2023 | 40.40 Mn |
| Jun 30, 2023 | 42.60 Mn |
| Mar 31, 2023 | 42.80 Mn |
| Dec 31, 2022 | 42.60 Mn |
| Dec 31, 2017 | 1.70 Mn |
| Dec 31, 2016 | 4.80 Mn |
| Dec 31, 2015 | 6.90 Mn |
| Dec 31, 2014 | 10.60 Mn |
API Access
Neurocrine Biosciences Goodwill & Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=goodwill-and-intangibles&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "goodwill-and-intangibles", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=goodwill-and-intangibles&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();